TP-0184

· Sumitomo Pharma America, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TP-0184, covering 2023-03-30 to 2023-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS [Phase 1, Phase 2]